Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03478956
Brief Title: A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease (FENNEL)

First Submitted : March 26, 2018
First Submitted that Met QC Criteria : March 26, 2018
First Posted : March 27, 2018

Results First Submitted : May 19, 2020
Results First Submitted that Met QC Criteria : July 21, 2020
Results First Posted : August 5, 2020

Last Update Submitted that Met QC Criteria : July 9, 2021
Last Update Posted : July 13, 2021